Chief Physician for the Department of Hematology, Specialty Affiliation Allogeneic Hematopoietic Stem Cell Transplantation with particular professional responsibility for transplantation of Acute Myeloid Leukemia

Center for Cancer and Organ Diseases, Department of Blood Diseases has a full-time position as Chief Physician available for occupancy from January 1, 2027.

Department's responsibilities and tasks

Department of Blood Diseases RH is a hematology department that handles all diagnoses and treatments within the specialty. The department has Region Hovedstaden as its catchment area, and has a national function for allogeneic stem cell transplantation and erythrocyte diseases, and covers the hematology function on the Faroe Islands.

The department has an extensive program for systematic teaching in blood diseases and related topics of internal medical interest.

The department has a large clinical research unit with many actively recruiting protocols, including phase 1 protocols as well as a recent establishment of the Blood Dose platform trial. In addition, there are strong research groups attached to the department that perform translational clinical research, basic research, and epidemiological research in relation to many hematological diagnoses.

The position

The position is a senior physician position with attachment to the specialist group for Allogeneic Hematopoietic Stem Cell Transplantation. The position is associated with on-call obligations, as one enters the hematology on-call function and has ward rounds on weekends and holidays, and participates in the specialized telephone advisory on allogeneic hematopoietic stem cell transplantation.

A role as the professional responsible for transplantation of patients with Acute Myeloid Leukemia is attached to the position.

Additionally attached is a function as scheduler for the myeloid and the allogeneic transplanting specialist group as well as the department's training physicians.

Candidate

The position is to be filled with a specialist in internal medicine; hematology, who at the time of joining has a minimum of 5 years' experience as a specialist in a hematology department, and who has substantial experience independently at the specialist level to undertake the responsibility for the entire patient care pathway within allogeneic hematopoietic stem cell transplantation.

Additionally, a colleague with particularly documented interest and experience within myeloid stem cell diseases is desired, who will be able to bear the professional responsibility for allogeneic transplantation of Acute Myeloid Leukemia.

With regard to the role in work planning, the recruitment process will place emphasis on experience with the on-call scheduling system Optima and coordination with operational processes. In addition, a colleague with good abilities in professional-cultural and interprofessional collaboration is sought.

A core value in Rigshospitalet's strategy is to be of benefit to the individual patient and to the healthcare system as a whole. This dualism requires attention to both overarching and political priorities as well as joint decision-making. With a view to the position's key role in referral and planning of allogeneic transplantation, a candidate who can document experience with regulatory processes as well as experience with initiative and co-leadership within treatment culture and value for the patient is desired.

Further information

Further information can be obtained by contacting Chief Physician Peter Kampmann at tel. 35 45 17 33.

Salary and employment conditions in accordance with the agreement between Danish Regions and the Association of Specialist Doctors.

The application is prepared in relation to the Health Authority's latest revision of the seven doctor roles from 2026 and is accompanied by a copy of specialist authorization as well as a CV documenting relevant experience in relation to the job posting.

Applications are submitted via the link on this page.

Application deadline October 31, 2026.

After the application deadline, a written suitability assessment will be carried out based on the application and CV by two chief physicians at highly specialized Danish hematology departments and invited for interview thereafter.